BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 34901148)

  • 1. LRMP Associates With Immune Infiltrates and Acts as a Prognostic Biomarker in Lung Adenocarcinoma.
    Jin X; Chen L; Zhou N; Ni H; Zu L; He J; Yang L; Zhu Y; Sun X; Li X; Xu S
    Front Mol Biosci; 2021; 8():711928. PubMed ID: 34901148
    [No Abstract]   [Full Text] [Related]  

  • 2. [The Expression of RTN1 in Lung Adenocarcinoma and 
Its Effect on Immune Microenvironment].
    Zhu S; Zu L; Xu S
    Zhongguo Fei Ai Za Zhi; 2022 Jun; 25(6):385-395. PubMed ID: 35747917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated analysis and validation reveal ACAP1 as a novel prognostic biomarker associated with tumor immunity in lung adenocarcinoma.
    Wang N; Zhu L; Xu X; Yu C; Huang X
    Comput Struct Biotechnol J; 2022; 20():4390-4401. PubMed ID: 36051873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SNCA correlates with immune infiltration and serves as a prognostic biomarker in lung adenocarcinoma.
    Zhang X; Wu Z; Ma K
    BMC Cancer; 2022 Apr; 22(1):406. PubMed ID: 35421944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer/testis antigen HEMGN correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma.
    Jiang Y; Yu L; Hu Q; Kang Y; You J; Huang C; Xu X; Chen L
    Mol Immunol; 2023 Jan; 153():226-237. PubMed ID: 36563642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DPYSL2 as potential diagnostic and prognostic biomarker linked to immune infiltration in lung adenocarcinoma.
    Wu YJ; Nai AT; He GC; Xiao F; Li ZM; Tang SY; Liu YP; Ai XH
    World J Surg Oncol; 2021 Sep; 19(1):274. PubMed ID: 34517904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased expression of JAK1 associated with immune infiltration and poor prognosis in lung adenocarcinoma.
    Cai J; Deng H; Luo L; You L; Liao H; Zheng Y
    Aging (Albany NY); 2020 Dec; 13(2):2073-2088. PubMed ID: 33323549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of ALG3 as a potential prognostic biomarker in lung adenocarcinoma.
    Yuan Y; Xie B; Guo D; Liu C; Jiang G; Lai G; Zhang Y; Hu X; Wu Z; Zheng R; Huang L
    Heliyon; 2023 Jul; 9(7):e18065. PubMed ID: 37539167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic biomarker TUBA1C is correlated to immune cell infiltration in the tumor microenvironment of lung adenocarcinoma.
    Bian T; Zheng M; Jiang D; Liu J; Sun H; Li X; Liu L; Zhang J; Liu Y
    Cancer Cell Int; 2021 Mar; 21(1):144. PubMed ID: 33653340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis to identify GNG7 as a prognostic biomarker in lung adenocarcinoma correlating with immune infiltrates.
    Wei Q; Miao T; Zhang P; Jiang B; Yan H
    Front Genet; 2022; 13():984575. PubMed ID: 36159963
    [No Abstract]   [Full Text] [Related]  

  • 11. TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma.
    Guo L; Li X; Liu R; Chen Y; Ren C; Du S
    Cancer Med; 2020 Sep; 9(18):6694-6709. PubMed ID: 32700817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between prognostic indicator AHNAK2 and immune infiltrates in lung adenocarcinoma.
    Zheng M; Liu J; Bian T; Liu L; Sun H; Zhou H; Zhao C; Yang Z; Shi J; Liu Y
    Int Immunopharmacol; 2021 Jan; 90():107134. PubMed ID: 33168407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates.
    Zhao R; Peng C; Song C; Zhao Q; Rong J; Wang H; Ding W; Wang F; Xie Y
    Int Immunopharmacol; 2020 Oct; 87():106828. PubMed ID: 32736193
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Zhang XZ; Chen MJ; Fan PM; Jiang W; Liang SX
    Int J Gen Med; 2022; 15():2727-2745. PubMed ID: 35300128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSF2RB Is a Unique Biomarker and Correlated With Immune Infiltrates in Lung Adenocarcinoma.
    Zhu N; Yang Y; Wang H; Tang P; Zhang H; Sun H; Gong L; Yu Z
    Front Oncol; 2022; 12():822849. PubMed ID: 35574409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GRAP2 is a prognostic biomarker and correlated with immune infiltration in lung adenocarcinoma.
    Song S; Deng X; Jiang S; Tian C; Han J; Chai J; Li N; Yan Y; Luo Z
    J Clin Lab Anal; 2022 Nov; 36(11):e24662. PubMed ID: 36181310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated profiling of endoplasmic reticulum stress-related DERL3 in the prognostic and immune features of lung adenocarcinoma.
    Lin L; Lin G; Lin H; Chen L; Chen X; Lin Q; Xu Y; Zeng Y
    Front Immunol; 2022; 13():906420. PubMed ID: 36275646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value and immune regulatory role of dynamin 1-like in lung adenocarcinoma.
    Song W; Wu X; Wang S; Barr MP; Rodríguez M; Oh IJ; Wu Y; Li D
    Transl Lung Cancer Res; 2023 Dec; 12(12):2476-2493. PubMed ID: 38205213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level.
    Wang W; Ren S; Wang Z; Zhang C; Huang J
    Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NcRNA-Mediated High Expression of
    Jiang X; Tang L; Yuan Y; Wang J; Zhang D; Qian K; Cho WC; Duan L
    Front Oncol; 2022; 12():846536. PubMed ID: 35311097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.